The transplantation program at Stanford Medicine has hit a milestone with its 1,000th procedure — performed on a 54-year-old woman with sarcoidosis. The surgery, carried under the Heart-Lung & Lung Transplantation Program at Stanford Health Care, is now part of the 750 lung transplants and 250 heart-lung…

I previously wrote about the challenge of living with sarcoidosis during the four seasons. Each season has its difficulties. Yet I can’t imagine living without the change in weather. I enjoy each season for what it has to offer. We’re well into winter in the Northeast. The cold, wind,…

While sarcoidosis affecting the testicles is rare, it can be a cause of infertility in men, according to a new case report. The report, “Sarcoidosis is a rare cause of infertility: A case report,” was published in Urology Case Reports. Sarcoidosis is characterized by the…

ATYR1923, aTyr Pharma’s lead investigational therapy for pulmonary sarcoidosis, is safe and well-tolerated, according to interim data from a Phase 1b/2a clinical trial. ATYR1923 is a first-in-class disease-modifying therapy  in development for the treatment of different types of interstitial lung diseases…

The holiday season is here once again. Before sarcoidosis, I embraced the holidays as a festive time. Things have changed since then. However, I have found a “recipe” for approaching the holiday season: a way to stay as stress-free and healthy as possible, despite my chronic illness. I…

The lungs of patients with sarcoidosis are burdened with a more active subset of immune T-cells, called mucosal-associated invariant T (MAIT) cells, a study reports. The activity of these MAIT cells correlates with worse disease, supporting their potential as therapeutic targets, the researchers said. The study, “…

Intermediate monocytes, a type of immune cell, may contribute to the development and progression of sarcoidosis through the production of TARC — a molecule that attracts other specific immune cells linked to inflammation, according to a small study. These findings point to intermediate monocytes and TARC as potential treatment targets…

More than 55 million people plan to travel 50 miles or more for Thanksgiving this year, according to AAA. But I won’t be among them. After two exhausting trips to Cleveland, all within a month, this self-proclaimed worst traveler is staying home. I love to travel, but trips wear…

Acthar Gel (repository corticotropin injection, or RCI) can improve sarcoidosis symptoms, a real-world study shows. Titled “Repository corticotropin injection in patients with advanced symptomatic sarcoidosis: retrospective analysis of medical records,” the study was published in the journal Therapeutic Advances in Respiratory Disease. Acthar Gel, marketed…

Before my diagnosis, I thought of myself as a traditionalist, at least when it came to the holidays. I baked cookies, decorated the house, and shopped for the perfect gift for everyone on my list. I planned get-togethers for family and friends and went to great lengths to pull off…